推荐产品
![MCA-[Asn670, Leu671]-Amyloid β/A4 Precursor Protein 770 Fragment 667-676-DNP-Lys-Arg-Arg-NH2 ≥90% (HPLC)](/deepweb/assets/sigmaaldrich/product/images/375/511/f63f11a7-86de-45c4-95a0-7afa616bb265/640/f63f11a7-86de-45c4-95a0-7afa616bb265.jpg)
用途
sufficient for 100 tests
品質等級
製造商／商標名
Calbiochem®
儲存條件
OK to freeze
avoid repeated freeze/thaw cycles
protect from light
輸入
sample type tissue extract(s)
sample type purified enzyme(s) (BACE)
sample type cell lysate
檢測方法
fluorometric
儲存溫度
−20°C
一般說明
一种灵敏的荧光检测试剂盒，用于测定 β-分泌酶（BACE）活性（最大激发波长：335-355 nm；最大发射波长：495-501 nm）。β-分泌酶是一种跨膜天冬氨酰蛋白酶，可水解膜结合的淀粉样蛋白前体蛋白。
成分
提取缓冲液，反应缓冲液，β分泌酶-底物，β-分泌酶蛋白（阳性对照），β-分泌酶抑制剂和说明书。
警告
毒性：多个毒性值，请参阅 MSDS（O）
原則
Calbiochem β-分泌酶活性检测试剂盒（荧光）用于测量细胞裂解液、组织提取物或纯化的酶制剂中的 β-分泌酶（BACE）活性。
準備報告
• 活化的 β-分泌酶用 10 µl ddH2O 重悬冻干的活化的 β-分泌酶。重悬后，等分并冷冻（-70°C），以免失去活性。
儲存和穩定性
自收到之日起，将试剂盒的所有组件储存于 -20°C。重悬活性 β-分泌酶后，等分并冷冻（-70°C）以避免失活。初次解冻试剂盒组件后，将提取缓冲液和 2X 反应缓冲液储存于 4°C。
其他說明
由于该运输中有害物质的性质，您的订单可能需要支付额外的运输费用。某些尺寸的产品可免除其他有害材料的运输费用。请与您当地的销售办事处联系，以获取有关这些费用的更多信息。
法律資訊
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
訊號詞
Danger
危險聲明
危險分類
Eye Dam. 1 - Muta. 2 - Skin Irrit. 2
儲存類別代碼
10 - Combustible liquids
3K3A-activated protein C blocks amyloidogenic BACE1 pathway and improves functional outcome in mice.
Divna Lazic et al.
The Journal of experimental medicine, 216(2), 279-293 (2019-01-17)
3K3A-activated protein C (APC), a cell-signaling analogue of endogenous blood serine protease APC, exerts vasculoprotective, neuroprotective, and anti-inflammatory activities in rodent models of stroke, brain injury, and neurodegenerative disorders. 3K3A-APC is currently in development as a neuroprotectant in patients with
Lei Liu et al.
The Journal of cell biology, 218(2), 644-663 (2019-01-11)
Intramembrane proteolysis of transmembrane substrates by the presenilin-γ-secretase complex is preceded and regulated by shedding of the substrate's ectodomain by α- or β-secretase. We asked whether β- and γ-secretases interact to mediate efficient sequential processing of APP, generating the amyloid
Crystal D Hayes et al.
BMC medicine, 11, 81-81 (2013-03-28)
Currently available therapies for Alzheimer's disease (AD) do not treat the underlying cause of AD. Anecdotal observations in nursing homes from multiple studies strongly suggest an inverse relationship between cancer and AD. Therefore, we reasoned that oncology drugs may be
Yan Cai et al.
Neurotoxicity research, 21(2), 160-174 (2011-07-05)
β-amyloid precursor protein (APP) and presenilins mutations cause early-onset familial Alzheimer's disease (FAD). Some FAD-based mouse models produce amyloid plaques, others do not. β-Amyloid (Aβ) deposition can manifest as compact and diffuse plaques; it is unclear why the same Aβ
Xue-Mei Zhang et al.
The European journal of neuroscience, 31(4), 710-721 (2010-04-14)
Cerebral hypometabolism and amyloid accumulation are principal neuropathological manifestations of Alzheimer's disease (AD). Whether and how brain/neuronal activity might modulate certain pathological processes of AD are interesting topics of recent clinical and basic research in the field, and may be
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门